Looking in a supervised way at expression of particular differentiation markers commonly used for immunohistochemical analysis of glial/glioneuronal tumors, we found low GFAP expression, and modest levels of OLIG2, NeuN (RBFOX3), MAP2 and synaptophysin (SYP). Here, MAP2 is linked to mixed neuronal-glial tumor.